Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2025-09-25 | 2026-01-08 | 267856 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-12-19 | 2025-02-28 | 246095 |
| TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2023-11-09 | 2024-01-11 | 209661 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2020-02-21 | 2020-04-02 | 106916 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-05-09 | 218126 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-05-16 | 2024-06-13 | 228140 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-27 | 2023-08-18 | 200203 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
| TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2025-09-11 | 2025-10-30 | 266976 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2022-06-30 | 2022-08-19 | 163909 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2025-07-18 | 2025-08-08 | 263101 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2025-11-06 | 2025-11-13 | 271205 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-20 | 2023-07-28 | 199306 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2020-03-26 | 2020-05-08 | 109583 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-10-05 | 2023-12-14 | 206392 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-12-02 | 2022-02-10 | 150403 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |